Soligenix Inc.

01/14/2025 | Press release | Distributed by Public on 01/14/2025 06:30

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma